VIVUS (VVUS) announced that it has joined with Aetna (AET) to integrate Qsymia capsules CIV into a pilot program designed to evaluate the benefits of prescription medication combined with lifestyle support for weight loss. The program is the first of its kind involving Qsymia and a health care benefits provider. The pilot is expected to provide insight regarding impact on health outcomes, workplace productivity and the potential for reductions in medical costs. The program is projected to run through year-end 2014. Pilot participation is being managed through Aetna.